1.
Kramer P. Dual Blockade of Inhibitory Immunoreceptors TIGIT and PD-1 Produces Optimal Synergistic Anti-Tumor Effects. MJUSc [Internet]. 2022 Oct. 3 [cited 2024 May 1];1(1):3-4. Available from: https://journals.ku.edu/MJUSc/article/view/18573